treatment of emergent adverse events in ovarian cancer
Published 4 years ago • 72 plays • Length 3:05Download video MP4
Download video MP3
Similar videos
-
1:12
dr. emens on immune-related adverse events in ovarian cancer
-
23:15
is it time to change upfront chemotherapy for ovarian cancer?
-
1:49
addressing fatigue as an adverse event in ovarian and uterine cancers
-
7:15
systemic management of ovarian cancer: closing thoughts
-
7:44
frontline treatments in ovarian cancer
-
1:13:10
the state of ovarian cancer: exploring the landscape of systemic therapy
-
7:09
biomarker-driven frontline ovarian cancer treatment
-
5:02
novel agents and the future treatment of ovarian cancer
-
7:26
emerging therapies in recurrent ovarian cancer
-
0:41
understand the adverse events of parp inhibitors
-
9:08
factors in choice of treatment for recurrent ovarian cancer
-
1:50
dr. moore on results of the forward i/gog 3011 trial in ovarian cancer
-
7:16
new options for recurrent ovarian cancer
-
4:37
frontline ovarian cancer management: ongoing clinical trials
-
1:34
dr. kristeleit on the safety profile of rucaparib in ovarian cancer
-
59:14
parp inhibitors in ovarian cancer: clinical updates from sgo 2023
-
8:15
bevacizumab in ovarian cancer
-
6:44
sequencing for treatment for recurrent ovarian cancer
-
2:13
improving outcomes in ovarian cancer